Facebook Twitter
Now With Over 22,000 Reviews!
Sign up now and see how you can quickly earn 20 ivBucks.

Phase 1 Investor

Phase 1 Investor is our most exclusive and expensive investment advisory at Stansberry Research. Written by our resident biotech expert Rob Fannon, the service primarily focuses on emerging technologies.

 
 
 
4 Total Reviews
Overall:
 
5-Star       (0)
4-Star       (0)
3-Star       (0)
2-Star       (1)
1-Star       (3)
   
Top Review
 
 
Show:  
Sort:  
Page:   1
Displaying 1-4 of 4 Total Reviews
The following review is from www.stockgumshoe.com
Never subscrided to this letter.
Never subscrided to this letter. Subscride to S & A report

so I get all the hype S & A dishes out for you to buy this expensive letter. So my comment will be limited to their

“hawking” of ARNA. Such hype—-2 years of research—$200,000 spent for research—invest 5thou or 10 thou and retire.

It was easy to figure out the name of this stock even though I don’t buy the stock letter (thank GOD). ARNA was in the news, on TV. I wonder what PHASE 1 spent their $200,000 on.

Any way stock doesn’t pass phase

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
1 of 1 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.
External Website

Overall Rating



The following review is from www.stockgumshoe.com
does not seem to “get” stock valuation
Hey, Rob L., Phase 1 never recommended buying ARNA! They said DON’T buy the stock, buy a call spread. They sold the spread after the announcement for a 40% loss and then recommended selling the July $2.50 put for enough money to get the loss back.

But, overall, Phase 1 does not seem to “get” stock valuation, and tends to gloss over the negatives, so a lot of their recommendations hit their 25% stop loss and disappear.

Plus, it is really expensive.

Disclosure: My newsletter, New World Investor

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
1 of 1 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.
External Website

Overall Rating



The following review is from www.stockgumshoe.com
Remember this teaser?
Remember this teaser?

“On March 30, FDA results we’ve waited 2 years to receive could make you $195,600, overnight!”

Well, March 30 has arrived! The results are in! And indeed you COULD have made $195,600…if you had SHORTED Arena Pharmaceuticals instead of BUYING it, the way Phase One pounded the table to have you do! Rather than soar over $10 a share, which could “change your life” and “allow you to literally quit work, forever!”…the stock plunged from $4.50 to a low of $2.85 today, before...

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
1 of 1 people have found this review helpful.
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.
External Website

Overall Rating



The following review is from www.stockgumshoe.com
mostly in tech and biotech.
Focuses on small, potential explosive growth companies, mostly in tech and biotech.

This review is the subjective opinion of an Investimonials member and not of Investimonials LLC
Embed Permalink Report
Was this review helpful?   Yes   No
Review Updated


This review is the subjective opinion of an Investimonials.com member and not of Investimonials LLC.
External Website

Overall Rating



Page:   1
Displaying 1-4 of 4 Total Reviews
Recommended For
 
Investimonials Sponsors
 
Featured Investing Products